ASH 2022—new developments in acute myeloid leukemia
memo - Magazine of European Medical Oncology（2023）
摘要
Summary Recent years have provided progress for the treatment of acute myeloid leukemia (AML) patients by translating insights from basic research on AML biology into new drugs and concepts. The latest developments presented at the 2022 annual meeting of the American Society of Hematology (ASH) are covered in this review, including discussion of new classifications, treatment of elderly unfit patients, and new approaches towards allogeneic transplantation.
更多查看译文
关键词
Prognosis,Classification,Elderly Patients,Targeted molecular therapy,Allogeneic transplantation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要